Related Experiment Videos

Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry

A Takada1, S Watanabe, H Ito

  • 1Laboratory of Microbiology, Graduate School of Veterinary Medicine, Sapporo, 060-0818, Japan.

Virology
|December 9, 2000
PubMed

Insights

Ebola virus glycoprotein (GP) causes cell damage by altering cell shape and adhesion. This viral protein downregulates beta1 integrins, potentially aiding virus entry into host cells.

Area of Science:

  • Virology
  • Cell Biology
  • Molecular Biology

Background:

  • Filoviruses, such as Ebola virus, exhibit cytotoxic effects on host cells.
  • The Ebola virus glycoprotein (GP) is a key viral component mediating host cell interactions.

Purpose of the Study:

  • To investigate the role of Ebola virus glycoprotein (GP) in cellular damage and identify its molecular mechanisms.
  • To determine if GP expression induces specific morphologic changes in host cells.

Main Methods:

  • Transient expression of wild-type and chimeric Ebola virus GP in human kidney 293T cells.
  • Analysis of cell morphology (rounding, detachment) and expression of cell adhesion molecules, specifically beta1 integrins.
  • Functional assays using anti-beta1 monoclonal antibodies and purified integrins to assess viral infectivity.

Main Results:

  • Expression of wild-type GP, but not its secretory form, induced cell rounding and detachment.
  • GP anchorage to the cell membrane and its ectodomain were essential for inducing these morphologic changes.
  • GP expression led to the downregulation of beta1 integrins.
  • Inhibition of beta1 integrins or their interaction with GP reduced the infectivity of pseudotyped viruses.

Conclusions:

  • Ebola virus GP induces cytopathic effects through mechanisms involving cell adhesion molecule downregulation.
  • Beta1 integrins are implicated in the interaction with Ebola virus GP and may play a role in viral entry into host cells.

Related Concept Videos